EXAMINE THIS REPORT ON KITAMAIN

A March report from the Institute for Medical and Financial Evaluate, an independent analysis team, questioned the corporation's clinical trial benefits and challenged the objectivity of MDMA advocates who participated during the study as the two clients and therapists.Steep, crisscrossing paths into the summit enable it to be difficult to discern